China Dasheng Biotechnology Company

China Dasheng Biotechnology Company

CDBT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.1M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
China Dasheng Biotechnology CompanyChina Dasheng Biotechnology Company-35-164%--1.5
$-0.02

Current Fair Value

124.9% downside

Overvalued by 124.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.10 Million
Enterprise Value$4.17 Million
Earnings per Share$-0.02
Beta2.26
Outstanding Shares40,976,000

Return

Return on Equity163.89%ROE
Return on Assets-144.14%
Return on Invested Capital184.53%

Valuation & Multiples

P/E Ratio-35P/E Ratio
PEG-36.11PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.1Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-45.13
Enterprise Value to Net Income-51
Total Debt to Enterprise0.02
Debt to Equity-1.52Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Cycclone Inc.

689 employees
CEO: Michael Nugent

Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal f...